C. Migliorini, T. Lavé, N. Parrott, M. Reddy, H. Grimm, R. Penland, A. Soubret, G. Helmlinger, A. Georgieva, K. Zuideveld
{"title":"Systems Toxicology Modeling for Prediction in Humans","authors":"C. Migliorini, T. Lavé, N. Parrott, M. Reddy, H. Grimm, R. Penland, A. Soubret, G. Helmlinger, A. Georgieva, K. Zuideveld","doi":"10.1002/9780470744307.GAT233","DOIUrl":null,"url":null,"abstract":"This chapter aims to illustrate the ability of physiologically based mechanistic mathematical models to predict pharmacokinetics and toxicity across species. The underlying principle is that toxicity must be interpreted in the physiological context where it is measured. \n \n \n \nVarious methodologies for predicting the pharmacokinetics, QT prolongation and proarrhythmic risk are evaluated. Finally an integration of both pharmacokinetics and toxicokinetics in chemotherapy-induced neutropenia is discussed. It is believed that the methodologies presented for integrating available knowledge across experiments to predict toxicology in humans will ultimately make drug development more efficient, cost cost-effective, and socially more acceptable. \n \n \nKeywords: \n \npharmacokinetics; \nPBPK; \ntoxicokinetics; \nQT prolongation; \ncardiac; \nelectrophysiology; \nmyelosuppression; \nneutropenia","PeriodicalId":325382,"journal":{"name":"General, Applied and Systems Toxicology","volume":"71 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2011-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"General, Applied and Systems Toxicology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/9780470744307.GAT233","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
This chapter aims to illustrate the ability of physiologically based mechanistic mathematical models to predict pharmacokinetics and toxicity across species. The underlying principle is that toxicity must be interpreted in the physiological context where it is measured.
Various methodologies for predicting the pharmacokinetics, QT prolongation and proarrhythmic risk are evaluated. Finally an integration of both pharmacokinetics and toxicokinetics in chemotherapy-induced neutropenia is discussed. It is believed that the methodologies presented for integrating available knowledge across experiments to predict toxicology in humans will ultimately make drug development more efficient, cost cost-effective, and socially more acceptable.
Keywords:
pharmacokinetics;
PBPK;
toxicokinetics;
QT prolongation;
cardiac;
electrophysiology;
myelosuppression;
neutropenia